Absorption |
Blood-Brain Barrier | BBB+ | 0.9911 |
Human Intestinal Absorption | HIA+ | 0.9900 |
Caco-2 Permeability | Caco2+ | 0.7151 |
P-glycoprotein Substrate | Substrate | 0.7886 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7593 |
Inhibitor | 0.5358 |
Renal Organic Cation Transporter | Inhibitor | 0.6894 |
Distribution |
Subcellular localization | Mitochondria | 0.6199 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8015 |
CYP450 2D6 Substrate | Substrate | 0.5494 |
CYP450 3A4 Substrate | Substrate | 0.6298 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5169 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8812 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5356 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7374 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8153 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5265 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6201 |
Non-inhibitor | 0.6721 |
AMES Toxicity | Non AMES toxic | 0.7465 |
Carcinogens | Non-carcinogens | 0.9306 |
Fish Toxicity | High FHMT | 0.9628 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9268 |
Honey Bee Toxicity | Low HBT | 0.6248 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.5636 |
Carcinogenicity (Three-class) | Non-required | 0.5404 |